NCT03355638View on ClinicalTrials.gov

Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2017

Conditions
Macular Edema
Interventions
DRUG

Aflibercept Injection [Eylea]

patients received monthly 0.5 mg aflibercept intravitreal injections for 3 months, after which monthly injections were administered pro re nata

DRUG

Pranoprofen Eyedrops

Patients were given a bottle of eyedrops for self-administration of 0.1% pranoprofen (Pranoflog, Sifi SpA, Aci Sant'Antonio, CT, Italy). Pranoprofen dosage was 1 drop in the study eye, 3 times a day, over the 12-month study period

DRUG

Omega-3 Supplementation

Ppatients were given daily tablets of Omega-3 supplementation provided free of charge by the company (Azyr Mega; Sifi SpA, Aci Sant'Antonio, CT, Italy).

All Listed Sponsors
lead

Università degli Studi di Brescia

OTHER

NCT03355638 - Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 | Biotech Hunter | Biotech Hunter